Table 5 Likelihood of Completing the Pneumococcal Vaccination Series by Interventions in Immunocompetent Adults aged 65+ (Mixed effects logistic regression)
OR | p-value | 95% Conf. Interval | ||
|---|---|---|---|---|
Intervention | ||||
Current practice (ref) | ||||
HM Only | 1.83 | <.0001 | 1.39 | 2.40 |
Revised BPA + HM | 1.48 | 0.019 | 1.07 | 2.05 |
Workflow redesign only | 0.53 | 0.005 | 0.34 | 0.82 |
Revised BPA + HM + Workflow redesign | 1.55 | 0.014 | 1.09 | 2.19 |
Age at time of first dose (ref 65 years) | ||||
66–75 | 0.57 | <.0001 | 0.44 | 0.73 |
> 75 | 0.34 | <.0001 | 0.24 | 0.48 |
Gender (ref male) | ||||
Female | 1.06 | 0.578 | 0.85 | 1.33 |
Insurance Status (ref Medicare) | ||||
Medicaid | 1.27 | 0.642 | 0.46 | 3.51 |
Commercial | 1.43 | 0.007 | 1.10 | 1.85 |
Uninsured | 1.29 | 0.481 | 0.64 | 2.58 |
Other | 2.07 | 0.617 | 0.12 | 36.07 |
Charlson Comorbidity Index | 1.00 | 0.914 | 0.94 | 1.08 |
Chronic heart disease | 0.64 | 0.011 | 0.45 | 0.90 |
Pre-index factors | ||||
Prior Pneumonia-Related Diagnosis | 0.97 | 0.894 | 0.63 | 1.50 |
Number of office visits 12-mos pre-index | 1.02 | 0.345 | 0.98 | 1.07 |